Clayton D. English, Pharm.D., BCPS, BCPP

Bio: 

Education

  • Specialty Residency in Clinical Psychopharmacology-Nova Southeastern University/South Florida State Hospital, Fort Lauderdale-Davie, FL
  • Doctor of Pharmacy-University of Connecticut, Storrs, CT
  • Bachelor of Science in Pharmacy Studies-University of Connecticut, Storrs, CT

Courses Taught at ACPHS

  • PHM 517 Psychopharmacology & Psychopathology in Film & Media
  • PSC 335 Drugs of Abuse/Co-coordinator
  • IPS 402 Integrated Problem Solving IV/Facilitator
  • PTP 549 Neurology/Psychology/Co-coordinator
  • PHM 549 Pharmacogenomics/Instructor
  • Advanced Pharmacy Practice Clerkship-Psychiatry I   

Research & Clinical Interests

  • Psychopharmacology
  • Consultation-Liaison Psychiatry
  • Health-Systems Pharmacy/Inpatient Psychiatry
  • Interdisciplinary Education
  • Pharmacy & Medical Resident Education

Clinical Practice

  • University of Vermont Medical Center - Inpatient Psychiatry, Burlington, VT

Selected Publications

English C, Aloi JJ. New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis. Clin Ther. 2015;37(4):691-715.

Ehret MJ, English CD. Alzheimer’s Disease. In: Chisholm-Burns MA, Wells BG, Schwinghammer TL, et al. Pharmacotherapy principles & practice. 3rd ed. New York: McGraw-Hill; 2013.

Marino J, English C, Caballero J, Harrington C. The role of paliperidone extended-release for the treatment of bipolar disorder. Neuropsychiatric Dis Treatment. 2012;8:181-9.

English C, Rey JA, Schlesselman LS. Prevalence of hazardous alcohol use among pharmacy students at nine U.S. schools of pharmacy. Pharmacy Practice (Internet) 2011 Jul-Sep;9(3):162-168.

Harrington CA, English C. Adverse drug events related to ziprasidone: a meta-analysis of randomized, placebo-controlled trials. Pharmacotherapy 2011;31(9):840-849.

Harrington CA, English C. Tolerability of paliperidone: a meta-analysis of randomized controlled trials. Int Clin Psychopharmacol. 2010 Nov; 25(6):334-41  

English C., Ray JA. Rufin C. Milnacipran (Savela®): A new SNRI for the treatment of fibromyalgia. P&T 2010; 35(5):262-266

Professional Licensure

  • Board Certified Psychiatric Pharmacist
  • Board Certified Pharmacotherapy Specialist
  • Vermont Pharmacist Preceptor 
  • Vermont Pharmacist 
  • Florida Pharmacist

College Service

  • Drug Utilization Review Board-Vermont Medicaid
  • Academic Standings Appeals Committee
  • Educational Resource Committee
  • Co-advisor: APhA-ASP VT Chapter

 

Professional Affiliations

  • American Society of Clinical Psychopharmacology
  • Vermont Society of Health SystemsPharmacists
  • College of Psychiatric and Neurologic Pharmacists
  • American College of Clinical Pharmacy
  • American Pharmacists Association
Associate Professor
Department of Pharmacy Practice